# Tissue Transplant Technology, Ltd. – FDA Inspection, May 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/tissue-transplant-technology-ltd/22f58abb-4289-42db-b4ee-ea32a819da26
Source feed: FDA_Inspections

> FDA inspection 1230830 of Tissue Transplant Technology, Ltd., May 03, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230830
- Company Name: Tissue Transplant Technology, Ltd.
- Inspection Date: 2024-05-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1162516 - 2022-02-18
- [FDA Inspection 1048948 - 2018-04-19](https://www.keypedia.com/records/fda_inspections/tissue-transplant-technology-ltd/703889a8-c028-46e6-88af-35dcf9acf4c8)
- FDA Inspection 1027128 - 2017-08-09
- FDA Inspection 929262 - 2015-06-08
- FDA Inspection 867668 - 2014-02-25

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)
- [Issuing Officer](https://www.keypedia.com/people/michael-a-blaine/784b203b-0a44-4f30-a4a7-1c2aa955defb)

Company: https://www.keypedia.com/companies/tissue-transplant-technology-ltd/2180844e-0a1f-43c4-85d6-7b9973ddf38c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
